Profil
Ariel G.
Notcovich is currently the Chief Operations & Technical Officer at Biolog, Inc. He was previously the Chief Executive Officer & Director at BlueLight Therapeutics, Inc.
Postes actifs de Ariel G. Notcovich
| Sociétés | Poste | Début |
|---|---|---|
Biolog, Inc.
 Biolog, Inc. Medical SpecialtiesHealth Technology Biolog, Inc. enages in the manufacture of diagnostic substances. It offers microbial identification, phenotype microarrays for microbial and mammalian cells, mitochondria function assays, educational porta, microbiome, microbial community analysis, and microbial detection. The company was founded by Barry R. Bochner and Donald W. Barnby in 1984 and is headquartered in Hayward, CA. | Directeur des opérations | 12/05/2022 |
Anciens postes connus de Ariel G. Notcovich
| Sociétés | Poste | Fin |
|---|---|---|
BlueLight Therapeutics, Inc.
 BlueLight Therapeutics, Inc. BiotechnologyHealth Technology BlueLight Therapeutics, Inc. develops novel systems to analyze real-time protein function for research and clinical applications. The firm offers technology for detecting conformational change in proteins and other biological molecules. Its technology is based on a phenomenon called second-harmonic generation (SHG), can monitor structural changes at any site within a protein, in real time and since protein function is determined by its structure, and changes in structure cause changes in function, characterizing these changes will provide significant insights into how the body functions and respond to treatments. The company was founded by Joshua S. Salafsky and Greg S. Yap in 2013 and is headquartered in South San Francisco, CA. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
BlueLight Therapeutics, Inc.
BlueLight Therapeutics, Inc. BiotechnologyHealth Technology BlueLight Therapeutics, Inc. develops novel systems to analyze real-time protein function for research and clinical applications. The firm offers technology for detecting conformational change in proteins and other biological molecules. Its technology is based on a phenomenon called second-harmonic generation (SHG), can monitor structural changes at any site within a protein, in real time and since protein function is determined by its structure, and changes in structure cause changes in function, characterizing these changes will provide significant insights into how the body functions and respond to treatments. The company was founded by Joshua S. Salafsky and Greg S. Yap in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
Biolog, Inc.
Biolog, Inc. Medical SpecialtiesHealth Technology Biolog, Inc. enages in the manufacture of diagnostic substances. It offers microbial identification, phenotype microarrays for microbial and mammalian cells, mitochondria function assays, educational porta, microbiome, microbial community analysis, and microbial detection. The company was founded by Barry R. Bochner and Donald W. Barnby in 1984 and is headquartered in Hayward, CA. | Health Technology |